↓ Skip to main content

Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

Overview of attention for article published in Cancer Research and Treatment : Official Journal of Korean Cancer Association, December 2011
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley